SLC5A2 and kidney disorder: By exploring the improved kidney outcomes with SGLT2 inhibition in adults and the limited data available for SGLT2 inhibition in children and youth with kidney disease, this review aims to highlight the need for robust and well-funded evaluation of SGLT2 inhibitors for treatment of kidney disease in pediatric patients.